Cancer-related anemia and recombinant human erythropoietin--an updated overview

Nature Clinical Practice. Oncology
Julia BohliusAndreas Engert

Abstract

For cancer patients, anemia can be a debilitating problem that negatively influences their overall quality of life and worsens their prognosis. The condition is caused either by the cancer itself or by cytotoxic treatment. Anemia is the primary indication for transfusion of red blood cells, but the development of recombinant human erythropoietins (epoetins) provides an alternative to red blood cell transfusions. Treatment with epoetins has been shown to reduce transfusion rates and increase hemoglobin response. There is some evidence that epoetins improve quality of life. It remains unclear, however, whether erythropoietin affects tumor growth and survival, and this area requires further investigation. Data from clinical trials suggest that erythropoietin increases the risk of thromboembolic complications. In the management of anemic patients, physicians should follow closely the dosing recommendations in products' package inserts or the ASCO/American Society of Hematology guidelines. Treatment of patients beyond the correction of anemia, however, has to be regarded as experimental and is potentially harmful, so should only be conducted in clinical trials.

References

Dec 1, 1991·Clinical Pharmacology and Therapeutics·C E HalstensonP A Abraham
Jun 14, 1990·The New England Journal of Medicine·C B MillerJ L Spivak
Apr 21, 1989·Cell·A D D'AndreaG G Wong
Apr 1, 1995·The Journal of Clinical Investigation·P A Wood, W J Hrushesky
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R Abels
Jan 1, 1993·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M HöckelP Vaupel
May 19, 1993·Journal of the National Cancer Institute·D C CaseC R Nichols
Jan 1, 1996·Cancer Treatment Reviews·J C de Haes, A M Stiggelbout
Mar 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J GlaspyS Vadhan-Raj
Feb 11, 1999·The New England Journal of Medicine·L T GoodnoughJ P AuBuchon
Apr 22, 1999·Anti-cancer Drugs·D SchrijversJ B Vermorken
Oct 8, 1999·Journal of the National Cancer Institute·J E Groopman, L M Itri
May 1, 2001·British Journal of Haematology·M F MurphyUNKNOWN British Committee for Standards in Haematology, Blood Transfusion Task Force
Jun 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T J LittlewoodUNKNOWN Epoetin Alfa Study Group
Jun 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J L GabriloveL H Einhorn
Jun 8, 2001·Seminars in Oncology·H Ludwig, K Strasser
Aug 14, 2001·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·M A Blajchman, P C Hébert
Mar 21, 2002·The Lancet Oncology·Andrew BottomleyBenjamin Djulbegovic
May 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anders OsterborgUNKNOWN Epoetin Beta Hematology Study Group
Jul 16, 2002·Laboratory Investigation; a Journal of Technical Methods and Pathology·Murat O ArcasoyZishan A Haroon
Jul 19, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B HolznerB Sperner-Unterweger
Aug 22, 2002·Journal of the National Cancer Institute·Johan VansteenkisteUNKNOWN Aranesp 980297 Study Group
Sep 25, 2002·BMC Cancer·Otavio ClarkBenjamin Djulbegovic
Sep 28, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J Douglas RizzoUNKNOWN American Society of Clinical Oncology. American Society of Hematology
Oct 19, 2002·The British Journal of Ophthalmology·S ArséneF Tranquart
Mar 26, 2003·International Journal of Radiation Oncology, Biology, Physics·Georg StübenPeter Vaupel
Apr 3, 2003·British Journal of Cancer·M BoogaertsUNKNOWN Epoetin beta QOL Working Group
Jul 25, 2003·British Journal of Haematology·Michael HedenusUNKNOWN Darbepoetin Alfa 20000161 Study Group
Aug 7, 2003·The Lancet Oncology·Brian Leyland-Jones, UNKNOWN BEST Investigators and Study Group
Aug 29, 2003·Lancet·Karin AhlbergVictoria Mock
Mar 18, 2004·Current Medical Research and Opinion·Anthony MorrealeMonica Schaefer
Mar 31, 2004·The American Journal of Medicine·Kevin KnightLodovico Balducci

❮ Previous
Next ❯

Citations

May 21, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Mary E Peterson
Jun 15, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Duong H NguyenAladar A Szalay
Sep 3, 2008·Veterinary Clinical Pathology·Julie WebbFrederic Almy
Jan 14, 2009·Journal of Veterinary Internal Medicine·A G MillerC S Olver
Aug 7, 2007·International Journal of Hematology·Toshiyuki KitanoMasanori Fukushima
Mar 28, 2013·International Journal of Clinical Oncology·Thomas ThomaidisUNKNOWN Upper-GI-Group of AIO (Arbeitsgemeinschaft Internistische Onkologie), Germany
Jul 18, 2009·International Journal of Hematology·Tommaso CaravitaPaolo de Fabritiis
Apr 4, 2015·Annual Review of Virology·Winnie M Chan, Grant McFadden
Feb 10, 2007·Current Medical Research and Opinion·Paul CornesJean-Jacques Zambrowski
Apr 25, 2009·Physical Medicine and Rehabilitation Clinics of North America·Andrea L Cheville
Jul 28, 2007·Critical Reviews in Oncology/hematology·Vivien M HodgesA Peter Maxwell
Mar 23, 2007·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Imke SatzgerRalf Gutzmer
Feb 19, 2011·Archives of Drug Information·Sergei A TjulandinAnton Buchner
Jan 4, 2007·The American Journal of Pathology·Balázs DömeJózsef Tímár
Mar 23, 2015·Blood Reviews·Neil ShahLawrence Tim Goodnough
Dec 30, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M AaproB Leyland-Jones
Dec 27, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Laura LabontéDavid Allan
May 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert PirkerJohan F Vansteenkiste
Apr 14, 2010·Human & Experimental Toxicology·Sonali PaulMadhusnata De
Nov 20, 2008·The Annals of Pharmacotherapy·Ashley M Newland, Curtis D Black
Feb 22, 2008·Journal of Cardiovascular Pharmacology·Vishal DiwanDhandeep Singh
Oct 9, 2013·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Alon D AltmanPrafull Ghatage
Jul 17, 2007·Journal of Peptide Science : an Official Publication of the European Peptide Society·Oscar Vadas, Keith Rose
May 8, 2020·Journal of Applied Physiology·William H NugentBjorn K Song
Apr 8, 2016·Current Opinion in Supportive and Palliative Care·Ronwyn van Eeden, Bernardo L Rapoport
Dec 13, 2018·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Shiv K SahSandhya Chapagain

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Related Papers

Transfusion clinique et biologique : journal de la Société française de transfusion sanguine
Peter Vaupel, Arnulf Mayer
Proceedings of the National Academy of Sciences of the United States of America
Michael BrinesAnthony Cerami
© 2021 Meta ULC. All rights reserved